These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9831071

  • 1. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C.
    J Cell Biochem; 1998 Dec 01; 71(3):340-50. PubMed ID: 9831071
    [Abstract] [Full Text] [Related]

  • 2. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.
    Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C.
    Oncogene; 1995 Nov 02; 11(9):1853-8. PubMed ID: 7478614
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity.
    Quack M, Mørk Hansen C, Binderup E, Kissmeyer AM, Carlberg C.
    Br J Pharmacol; 1998 Oct 02; 125(4):607-14. PubMed ID: 9831892
    [Abstract] [Full Text] [Related]

  • 4. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr 02; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 5. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M, Carlberg C.
    Mol Pharmacol; 1999 Jun 02; 55(6):1077-87. PubMed ID: 10347251
    [Abstract] [Full Text] [Related]

  • 6. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
    Quack M, Carlberg C.
    J Mol Biol; 2000 Feb 25; 296(3):743-56. PubMed ID: 10677278
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
    Issa LL, Leong GM, Sutherland RL, Eisman JA.
    J Bone Miner Res; 2002 May 25; 17(5):879-90. PubMed ID: 12009019
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors.
    Carlberg C, Mathiasen IS, Saurat JH, Binderup L.
    J Steroid Biochem Mol Biol; 1994 Nov 25; 51(3-4):137-42. PubMed ID: 7981122
    [Abstract] [Full Text] [Related]

  • 10. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S, Peräkylä M, Kärkkäinen JI, Steinmeyer A, Carlberg C.
    J Mol Biol; 2002 Jan 11; 315(2):229-38. PubMed ID: 11779241
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C.
    J Cell Biochem; 2003 Feb 01; 88(2):274-81. PubMed ID: 12520526
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR.
    J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M, Bury Y, Quack M, Uskokovic MR, Polly P, Carlberg C.
    Mol Pharmacol; 2000 Jun 01; 57(6):1206-17. PubMed ID: 10825392
    [Abstract] [Full Text] [Related]

  • 15. High-affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation.
    Nayeri S, Mathiasen IS, Binderup L, Carlberg C.
    J Cell Biochem; 1996 Sep 01; 62(3):325-33. PubMed ID: 8872604
    [Abstract] [Full Text] [Related]

  • 16. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
    Danielsson C, Fehsel K, Polly P, Carlberg C.
    Cell Death Differ; 1998 Nov 01; 5(11):946-52. PubMed ID: 9846181
    [Abstract] [Full Text] [Related]

  • 17. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A, Verlinden L, van Etten E, Shi L, Wu Y, D'Halleweyn C, Van Haver D, Zhu GD, Chen YJ, Zhou X, Haussler MR, De Clercq P, Vandewalle M, Van Baelen H, Mathieu C, Bouillon R.
    J Bone Miner Res; 2000 Feb 01; 15(2):237-52. PubMed ID: 10703925
    [Abstract] [Full Text] [Related]

  • 18. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M, Steinmeyer A, Carlberg C.
    Chem Biol; 2000 Nov 01; 7(11):885-94. PubMed ID: 11094341
    [Abstract] [Full Text] [Related]

  • 19. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H, Spinner D, Reddy GS, Lindley IJ.
    J Cell Biochem; 2000 Apr 01; 78(1):112-20. PubMed ID: 10797570
    [Abstract] [Full Text] [Related]

  • 20. Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance.
    Cheskis B, Freedman LP.
    Biochemistry; 1996 Mar 12; 35(10):3309-18. PubMed ID: 8605168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.